FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Stem Cell Rev Rep / Comparison of the Chondrogenic Potential of Mesenchymal Stem...
Stem cell reviews and reports2019; 16(1); 126-143; doi: 10.1007/s12015-019-09914-2

Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering.

Abstract: Osteoarthritis (OA) remains incurable in humans or horses and mesenchymal stromal/stem cells (MSCs) represent an attractive solution for producing a neocartilage substitute. However, the best MSC source still needs to be identified. This study compared the chondrogenic potential of equine MSCs derived from bone marrow (BM) and umbilical cord blood (UCB), at their undifferentiated status to check if one cell source is better proned, and after chondrogenic-induced differentiation. Chondrogenesis was induced by culture in collagen scaffold with BMP-2 + TGF-ß1 in hypoxia or normoxia. MSCs chondrogenic potential was evaluated using the mRNA and corresponding protein levels for osteogenic, hypertrophic and chondrogenic markers. MSCs characterization demonstrated that BM- and UCB-MSCs differ in proliferation and tripotencies. At undifferentiated status, they also showed differences in their expression of osteogenic, chondrogenic and hypertrophic markers. Upon chondrogenesis induction, both MSCs sources exhibited increased chondrogenic expression and produce an extracellular matrix (ECM) of better quality in hypoxia, although collagen I remained expressed. UCB-MSCs produced higher amounts of collagen II, particularly its IIB isoform, than BM-MSCs, but also collagen I and Htra1, regardless of the oxygen condition. Finally, immunohistochemistry revealed that the BM-MSCs synthesized an ECM of higher quality, regarding the more homogenous distribution of type IIB collagen, compared to UCB-MSCs. Considering collagen I as the major undesirable component in the neo-synthesis of in vitro cartilage, we recommend using BM-MSCs for horse cartilage engineering.
Get Full Text
Publication Date: 2019-11-21 PubMed ID: 31745710DOI: 10.1007/s12015-019-09914-2Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article delves into the comparison of the potential for cartilage production between bone marrow and umbilical cord blood-derived mesenchymal stem cells (MSCs) with the aim of finding a remedy for Osteoarthritis. The study suggests bone marrow MSCs to be the better choice for horse cartilage engineering due to the generation of a higher quality of extracellular matrix.

Introduction and Objectives

  • This study aims to provide a potential solution to Osteoarthritis (a currently incurable disease) by producing a neocartilage substitute using mesenchymal stromal/stem cells (MSCs).
  • The primary objective is to identify the best source of MSCs for this purpose by comparing those derived from bone marrow and umbilical cord blood.
  • The researchers studied these two potential sources of MSCs both in their undifferentiated state and after chondrogenic-induced differentiation.

Methodology

  • Chondrogenesis is induced in the MSCs using a culture in collagen scaffold with Bone Morphogenetic Protein (BMP-2) and TGF-ß1.
  • This induction process is carried out in two environments – hypoxia (low oxygen) and normoxia (normal oxygen).
  • The efficacy of the MSCs and their potential for chondrogenesis is evaluated using mRNA and corresponding protein levels for osteogenic, hypertrophic and chondrogenic markers.

Results

  • In their undifferentiated state, both bone marrow and umbilical cord blood MSCs exhibited differences in their expression of osteogenic, chondrogenic and hypertrophic markers.
  • Following chondrogenesis induction, both sources of MSCs showed increased chondrogenic expression and formed a higher quality of extracellular matrix in hypoxia.
  • However, it was noted that collagen I remained expressed in both cases.
  • Umbilical cord blood MSCs produced higher amounts of collagen II, particularly its IIB isoform, compared to bone marrow MSCs, but also produced higher amounts of collagen I and Htra1.
  • Surprisingly, bone marrow MSCs synthesized an extracellular matrix of higher quality, suggested by the presence of a more homogenous distribution of type IIB collagen, compared to umbilical cord blood MSCs.

Conclusion

  • Given the synthesis of collagen I (the major undesirable component in the in vitro synthesis of cartilage), the study recommends using bone marrow-derived MSCs for horse cartilage engineering.

Cite This Article

APA
Contentin R, Demoor M, Concari M, Desancé M, Audigié F, Branly T, Galéra P. (2019). Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering. Stem Cell Rev Rep, 16(1), 126-143. https://doi.org/10.1007/s12015-019-09914-2

Publication

Stem cell reviews and reports
ISSN: 2629-3277
NlmUniqueID: 101752767
Country: United States
Language: English
Volume: 16
Issue: 1
Pages: 126-143

Researcher Affiliations

Contentin, Romain
  • UNICAEN, BIOTARGEN, Normandie University, 14000, Caen, France.
Demoor, Magali
  • UNICAEN, BIOTARGEN, Normandie University, 14000, Caen, France.
Concari, Miranda
  • UNICAEN, BIOTARGEN, Normandie University, 14000, Caen, France.
Desancé, Mélanie
  • UNICAEN, BIOTARGEN, Normandie University, 14000, Caen, France.
Audigié, Fabrice
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université de Paris-Est, 14430, Goustranville, France.
Branly, Thomas
  • UNICAEN, BIOTARGEN, Normandie University, 14000, Caen, France.
Galéra, Philippe
  • UNICAEN, BIOTARGEN, Normandie University, 14000, Caen, France. philippe.galera@unicaen.fr.

MeSH Terms

  • Animals
  • Bone Morphogenetic Protein 2 / metabolism
  • Cartilage / growth & development
  • Cartilage / metabolism
  • Cell Differentiation / genetics
  • Cell Hypoxia / genetics
  • Cell Proliferation / genetics
  • Chondrocytes / metabolism
  • Chondrogenesis / genetics
  • Collagen Type I / genetics
  • Collagen Type II / genetics
  • Extracellular Matrix / genetics
  • Fetal Blood / cytology
  • Fetal Blood / transplantation
  • High-Temperature Requirement A Serine Peptidase 1 / genetics
  • Horses
  • Humans
  • Mesenchymal Stem Cell Transplantation / methods
  • Mesenchymal Stem Cells / metabolism
  • Osteoarthritis / pathology
  • Osteoarthritis / therapy
  • Osteogenesis / genetics
  • RNA, Messenger / genetics
  • Tissue Engineering
  • Transforming Growth Factor beta1 / metabolism

References

This article includes 29 references
  1. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.. Stem Cells 2006 May;24(5):1294-301.
    pubmed: 16410387doi: 10.1634/stemcells.2005-0342google scholar: lookup
  2. White JL, Walker NJ, Hu JC, Borjesson DL, Athanasiou KA. A Comparison of Bone Marrow and Cord Blood Mesenchymal Stem Cells for Cartilage Self-Assembly.. Tissue Eng Part A 2018 Aug;24(15-16):1262-1272.
    pubmed: 29478385doi: 10.1089/ten.TEA.2017.0424google scholar: lookup
  3. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    pubmed: 16923606doi: 10.1080/14653240600855905google scholar: lookup
  4. McLeod CM, Mauck RL. On the origin and impact of mesenchymal stem cell heterogeneity: new insights and emerging tools for single cell analysis.. Eur Cell Mater 2017 Oct 27;34:217-231.
    pubmed: 29076514doi: 10.22203/eCM.v034a14google scholar: lookup
  5. Desancé M, Contentin R, Bertoni L, Gomez-Leduc T, Branly T, Jacquet S, Betsch JM, Batho A, Legendre F, Audigié F, Galéra P, Demoor M. Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy.. Int J Mol Sci 2018 Feb 10;19(2).
    pubmed: 29439436doi: 10.3390/ijms19020537google scholar: lookup
  6. Rakic R, Bourdon B, Demoor M, Maddens S, Saulnier N, Galéra P. Differences in the intrinsic chondrogenic potential of equine umbilical cord matrix and cord blood mesenchymal stromal/stem cells for cartilage regeneration.. Sci Rep 2018 Sep 14;8(1):13799.
    pubmed: 30217993doi: 10.1038/s41598-018-28164-9google scholar: lookup
  7. Li H, Ghazanfari R, Zacharaki D, Lim HC, Scheding S. Isolation and characterization of primary bone marrow mesenchymal stromal cells.. Ann N Y Acad Sci 2016 Apr;1370(1):109-18.
    pubmed: 27270495doi: 10.1111/nyas.13102google scholar: lookup
  8. De Schauwer C, Piepers S, Van de Walle GR, Demeyere K, Hoogewijs MK, Govaere JL, Braeckmans K, Van Soom A, Meyer E. In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry.. Cytometry A 2012 Apr;81(4):312-23.
    pubmed: 22411893doi: 10.1002/cyto.a.22026google scholar: lookup
  9. Brooks PM. The burden of musculoskeletal disease--a global perspective.. Clin Rheumatol 2006 Nov;25(6):778-81.
    pubmed: 16609823doi: 10.1007/s10067-006-0240-3google scholar: lookup
  10. Branly T, Contentin R, Desancé M, Jacquel T, Bertoni L, Jacquet S, Mallein-Gerin F, Denoix JM, Audigié F, Demoor M, Galéra P. Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.. Int J Mol Sci 2018 Feb 1;19(2).
    pubmed: 29389887doi: 10.3390/ijms19020435google scholar: lookup
  11. Dewan AK, Gibson MA, Elisseeff JH, Trice ME. Evolution of autologous chondrocyte repair and comparison to other cartilage repair techniques.. Biomed Res Int 2014;2014:272481.
    pubmed: 25210707doi: 10.1155/2014/272481google scholar: lookup
  12. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.. N Engl J Med 1994 Oct 6;331(14):889-95.
    pubmed: 8078550doi: 10.1056/NEJM199410063311401google scholar: lookup
  13. Aubert-Foucher E, Mayer N, Pasdeloup M, Pagnon A, Hartmann D, Mallein-Gerin F. A unique tool to selectively detect the chondrogenic IIB form of human type II procollagen protein.. Matrix Biol 2014 Feb;34:80-8.
    pubmed: 24055103doi: 10.1016/j.matbio.2013.09.001google scholar: lookup
  14. Archer CW, Francis-West P. The chondrocyte.. Int J Biochem Cell Biol 2003 Apr;35(4):401-4.
    pubmed: 12565700doi: 10.1016/s1357-2725(02)00301-1google scholar: lookup
  15. McCarthy HE, Bara JJ, Brakspear K, Singhrao SK, Archer CW. The comparison of equine articular cartilage progenitor cells and bone marrow-derived stromal cells as potential cell sources for cartilage repair in the horse.. Vet J 2012 Jun;192(3):345-51.
    pubmed: 21968294doi: 10.1016/j.tvjl.2011.08.036google scholar: lookup
  16. Arufe MC, De la Fuente A, Fuentes I, de Toro FJ, Blanco FJ. Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes.. J Cell Biochem 2010 Nov 1;111(4):834-45.
    pubmed: 20665538doi: 10.1002/jcb.22768google scholar: lookup
  17. Branly T, Bertoni L, Contentin R, Rakic R, Gomez-Leduc T, Desancé M, Hervieu M, Legendre F, Jacquet S, Audigié F, Denoix JM, Demoor M, Galéra P. Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.. Stem Cell Rev Rep 2017 Oct;13(5):611-630.
    pubmed: 28597211doi: 10.1007/s12015-017-9748-ygoogle scholar: lookup
  18. Mobasheri A, Kalamegam G, Musumeci G, Batt ME. Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions.. Maturitas 2014 Jul;78(3):188-98.
    pubmed: 24855933doi: 10.1016/j.maturitas.2014.04.017google scholar: lookup
  19. Hackett CH, Flaminio MJ, Fortier LA. Analysis of CD14 expression levels in putative mesenchymal progenitor cells isolated from equine bone marrow.. Stem Cells Dev 2011 Apr;20(4):721-35.
    pubmed: 20722500doi: 10.1089/scd.2010.0175google scholar: lookup
  20. Demoor M, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Fabre H, Lafont J, Denoix JM, Audigié F, Mallein-Gerin F, Legendre F, Galera P. Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction.. Biochim Biophys Acta 2014 Aug;1840(8):2414-40.
    pubmed: 24608030doi: 10.1016/j.bbagen.2014.02.030google scholar: lookup
  21. Lo WC, Chen WH, Lin TC, Hwang SM, Zeng R, Hsu WC, Chiang YM, Liu MC, Williams DF, Deng WP. Preferential therapy for osteoarthritis by cord blood MSCs through regulation of chondrogenic cytokines.. Biomaterials 2013 Jul;34(20):4739-48.
    pubmed: 23557858doi: 10.1016/j.biomaterials.2013.03.016google scholar: lookup
  22. Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.. Cell Commun Signal 2011 May 14;9:12.
    pubmed: 21569606doi: 10.1186/1478-811X-9-12google scholar: lookup
  23. Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture.. Cell 1978 Dec;15(4):1313-21.
    pubmed: 729001doi: 10.1016/0092-8674(78)90056-9google scholar: lookup
  24. Pérez-Silos V, Camacho-Morales A, Fuentes-Mera L. Mesenchymal Stem Cells Subpopulations: Application for Orthopedic Regenerative Medicine.. Stem Cells Int 2016;2016:3187491.
    pubmed: 27725838doi: 10.1155/2016/3187491google scholar: lookup
  25. Mayer N, Lopa S, Talò G, Lovati AB, Pasdeloup M, Riboldi SA, Moretti M, Mallein-Gerin F. Interstitial Perfusion Culture with Specific Soluble Factors Inhibits Type I Collagen Production from Human Osteoarthritic Chondrocytes in Clinical-Grade Collagen Sponges.. PLoS One 2016;11(9):e0161479.
    pubmed: 27584727doi: 10.1371/journal.pone.0161479google scholar: lookup
  26. Brandt KD, Dieppe P, Radin EL. Etiopathogenesis of osteoarthritis.. Rheum Dis Clin North Am 2008 Aug;34(3):531-59.
    pubmed: 18687271doi: 10.1016/j.rdc.2008.05.011google scholar: lookup
  27. Kanawa M, Igarashi A, Ronald VS, Higashi Y, Kurihara H, Sugiyama M, Saskianti T, Pan H, Kato Y. Age-dependent decrease in the chondrogenic potential of human bone marrow mesenchymal stromal cells expanded with fibroblast growth factor-2.. Cytotherapy 2013 Sep;15(9):1062-72.
    pubmed: 23800732doi: 10.1016/j.jcyt.2013.03.015google scholar: lookup
  28. Braun J, Hack A, Weis-Klemm M, Conrad S, Treml S, Kohler K, Walliser U, Skutella T, Aicher WK. Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells.. Am J Vet Res 2010 Oct;71(10):1228-36.
    pubmed: 20919912doi: 10.2460/ajvr.71.10.1228google scholar: lookup
  29. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells.. Science 1999 Apr 2;284(5411):143-7.
    pubmed: 10102814doi: 10.1126/science.284.5411.143google scholar: lookup

Citations

This article has been cited 23 times.
  1. Zhang P, Dong B, Yuan P, Li X. Human umbilical cord mesenchymal stem cells promoting knee joint chondrogenesis for the treatment of knee osteoarthritis: a systematic review.. J Orthop Surg Res 2023 Aug 29;18(1):639.
    doi: 10.1186/s13018-023-04131-7pubmed: 37644595google scholar: lookup
  2. Venkatesan M, Zhang N, Marteau B, Yajima Y, De Zarate Garcia NO, Fang Z, Hu T, Cai S, Ford A, Olszewski H, Borst A, Coskun AF. Spatial subcellular organelle networks in single cells.. Sci Rep 2023 Apr 1;13(1):5374.
    doi: 10.1038/s41598-023-32474-ypubmed: 37005468google scholar: lookup
  3. Goh D, Yang Y, Lee EH, Hui JHP, Yang Z. Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review.. Bioengineering (Basel) 2023 Mar 13;10(3).
    doi: 10.3390/bioengineering10030355pubmed: 36978745google scholar: lookup
  4. Jammes M, Contentin R, Cassé F, Galéra P. Equine osteoarthritis: Strategies to enhance mesenchymal stromal cell-based acellular therapies.. Front Vet Sci 2023;10:1115774.
    doi: 10.3389/fvets.2023.1115774pubmed: 36846261google scholar: lookup
  5. Filippo M, Laura M, Riccardo G, Valeria V, Eschweiler J, Maffulli N. Mesenchymal stem cells augmentation for surgical procedures in patients with symptomatic chondral defects of the knee: a systematic review.. J Orthop Surg Res 2022 Sep 14;17(1):415.
    doi: 10.1186/s13018-022-03311-1pubmed: 36104803google scholar: lookup
  6. Guo X, Ma R, Wang M, Wui-Man Lau B, Chen X, Li Y. Novel perspectives on the therapeutic role of cryptotanshinone in the management of stem cell behaviors for high-incidence diseases.. Front Pharmacol 2022;13:971444.
    doi: 10.3389/fphar.2022.971444pubmed: 36046823google scholar: lookup
  7. Zhang W, Ling Q, Wang B, Wang K, Pang J, Lu J, Bi Y, Zhu D. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.. Stem Cell Res Ther 2022 Aug 8;13(1):406.
    doi: 10.1186/s13287-022-02974-1pubmed: 35941696google scholar: lookup
  8. Zhou H, Shen X, Yan C, Xiong W, Ma Z, Tan Z, Wang J, Li Y, Liu J, Duan A, Liu F. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.. Stem Cell Res Ther 2022 Jul 16;13(1):322.
    doi: 10.1186/s13287-022-03005-9pubmed: 35842714google scholar: lookup
  9. Contentin R, Jammes M, Bourdon B, Cassé F, Bianchi A, Audigié F, Branly T, Velot É, Galéra P. Bone Marrow MSC Secretome Increases Equine Articular Chondrocyte Collagen Accumulation and Their Migratory Capacities.. Int J Mol Sci 2022 May 21;23(10).
    doi: 10.3390/ijms23105795pubmed: 35628604google scholar: lookup
  10. Yari D, Ebrahimzadeh MH, Movaffagh J, Shahroodi A, Shirzad M, Qujeq D, Moradi A. Biochemical Aspects of Scaffolds for Cartilage Tissue Engineering; from Basic Science to Regenerative Medicine.. Arch Bone Jt Surg 2022 Mar;10(3):229-244.
    doi: 10.22038/ABJS.2022.55549.2766pubmed: 35514762google scholar: lookup
  11. Shahrbaf MA, Nouri M, Zarrabi M, Gramignoli R, Vosough M. Extraembryonic Mesenchymal Stromal/Stem Cells in Liver Diseases: A Critical Revision of Promising Advanced Therapy Medicinal Products.. Cells 2022 Mar 23;11(7).
    doi: 10.3390/cells11071074pubmed: 35406638google scholar: lookup
  12. O'Shea DG, Curtin CM, O'Brien FJ. Articulation inspired by nature: a review of biomimetic and biologically active 3D printed scaffolds for cartilage tissue engineering.. Biomater Sci 2022 May 17;10(10):2462-2483.
    doi: 10.1039/d1bm01540kpubmed: 35355029google scholar: lookup
  13. Liu S, Deng Z, Chen K, Jian S, Zhou F, Yang Y, Fu Z, Xie H, Xiong J, Zhu W. Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments (Review).. Mol Med Rep 2022 Mar;25(3).
    doi: 10.3892/mmr.2022.12615pubmed: 35088882google scholar: lookup
  14. Wang H, Wang Z, Liu H, Liu J, Li R, Zhu X, Ren M, Wang M, Liu Y, Li Y, Jia Y, Wang C, Wang J. Three-Dimensional Printing Strategies for Irregularly Shaped Cartilage Tissue Engineering: Current State and Challenges.. Front Bioeng Biotechnol 2021;9:777039.
    doi: 10.3389/fbioe.2021.777039pubmed: 35071199google scholar: lookup
  15. Liu Y, Shah KM, Luo J. Strategies for Articular Cartilage Repair and Regeneration.. Front Bioeng Biotechnol 2021;9:770655.
    doi: 10.3389/fbioe.2021.770655pubmed: 34976967google scholar: lookup
  16. Nino-Fong R, Esparza Gonzalez BP, Rodriguez-Lecompte JC, Montelpare W, McD￮ L. Development of a biologically immortalized equine stem cell line.. Can J Vet Res 2021 Oct;85(4):293-301.
    pubmed: 34602734
  17. Mollentze J, Durandt C, Pepper MS. An In Vitro and In Vivo Comparison of Osteogenic Differentiation of Human Mesenchymal Stromal/Stem Cells.. Stem Cells Int 2021;2021:9919361.
    doi: 10.1155/2021/9919361pubmed: 34539793google scholar: lookup
  18. Cozene BM, Russo E, Anzalone R, Rocca G, Borlongan CV. Mitochondrial activity of human umbilical cord mesenchymal stem cells.. Brain Circ 2021 Jan-Mar;7(1):33-36.
    doi: 10.4103/bc.bc_15_21pubmed: 34084975google scholar: lookup
  19. Bertoni L, Jacquet-Guibon S, Branly T, Desancé M, Legendre F, Melin M, Rivory P, Hartmann DJ, Schmutz A, Denoix JM, Demoor M, Audigié F, Galéra P. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model.. Int J Mol Sci 2021 Mar 2;22(5).
    doi: 10.3390/ijms22052499pubmed: 33801461google scholar: lookup
  20. Um S, Ha J, Choi SJ, Oh W, Jin HJ. Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells.. World J Stem Cells 2020 Dec 26;12(12):1511-1528.
    doi: 10.4252/wjsc.v12.i12.1511pubmed: 33505598google scholar: lookup
  21. Bourdon B, Contentin R, Cassé F, Maspimby C, Oddoux S, Noël A, Legendre F, Gruchy N, Galéra P. Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids.. Int J Mol Sci 2021 Jan 8;22(2).
    doi: 10.3390/ijms22020580pubmed: 33430111google scholar: lookup
  22. Neybecker P, Henrionnet C, Pape E, Grossin L, Mainard D, Galois L, Loeuille D, Gillet P, Pinzano A. Respective stemness and chondrogenic potential of mesenchymal stem cells isolated from human bone marrow, synovial membrane, and synovial fluid.. Stem Cell Res Ther 2020 Jul 25;11(1):316.
    doi: 10.1186/s13287-020-01786-5pubmed: 32711576google scholar: lookup
  23. Russo E, Lee JY, Nguyen H, Corrao S, Anzalone R, La Rocca G, Borlongan CV. Energy Metabolism Analysis of Three Different Mesenchymal Stem Cell Populations of Umbilical Cord Under Normal and Pathologic Conditions.. Stem Cell Rev Rep 2020 Jun;16(3):585-595.
    doi: 10.1007/s12015-020-09967-8pubmed: 32185666google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.